{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T08:22:31Z","timestamp":1794558151193,"version":"4.9.1"},"reference-count":202,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.cbi.2026.112315","type":"journal-article","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:06:20Z","timestamp":1788221180000},"page":"112315","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Carbonyl reductase 1: A redox-regulating carbonyl detoxification enzyme in health and disease"],"prefix":"10.1016","volume":"439","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0578-9672","authenticated-orcid":false,"given":"Satoshi","family":"Endo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Miura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiyuki","family":"Matsunaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Hara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbi.2026.112315_bib1","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1186\/1479-7364-3-4-362","article-title":"Aldo-keto reductase (AKR) superfamily: genomics and annotation","volume":"3","author":"Mindnich","year":"2009","journal-title":"Hum. Genom."},{"key":"10.1016\/j.cbi.2026.112315_bib2","doi-asserted-by":"crossref","first-page":"6003","DOI":"10.1021\/bi00018a001","article-title":"Short-chain dehydrogenases\/reductases (SDR)","volume":"34","author":"J\u00f6rnvall","year":"1995","journal-title":"Biochemistry"},{"key":"10.1016\/j.cbi.2026.112315_bib3","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1146\/annurev.pharmtox.47.120505.105316","article-title":"Carbonyl reductases: the complex relationships of mammalian carbonyl- and quinone-reducing enzymes and their role in physiology","volume":"47","author":"Oppermann","year":"2007","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.cbi.2026.112315_bib4","doi-asserted-by":"crossref","first-page":"96","DOI":"10.3109\/03602532.2013.853078","article-title":"Carbonyl reduction pathways in drug metabolism","volume":"46","author":"Mal\u00e1tkov\u00e1","year":"2014","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.cbi.2026.112315_bib5","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3109\/03602532.2011.638304","article-title":"Human microsomal carbonyl reducing enzymes in the metabolism of xenobiotics: well-known and promising members of the SDR superfamily","volume":"44","author":"Skarydov\u00e1","year":"2012","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.cbi.2026.112315_bib6","doi-asserted-by":"crossref","first-page":"639","DOI":"10.2174\/138920010794233530","article-title":"Human carbonyl reductases","volume":"11","author":"Mal\u00e1tkov\u00e1","year":"2010","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.cbi.2026.112315_bib7","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1080\/17425255.2017.1356820","article-title":"The role of carbonyl reductase 1 in drug discovery and development","volume":"13","author":"Shi","year":"2017","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.cbi.2026.112315_bib8","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.febslet.2005.11.049","article-title":"Differences in catalytic activity between rat testicular and ovarian carbonyl reductases are due to two amino acids","volume":"580","author":"Sciotti","year":"2006","journal-title":"FEBS Lett."},{"key":"10.1016\/j.cbi.2026.112315_bib9","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1006\/bbrc.1996.5995","article-title":"Identification of two closely related genes, inducible and noninducible carbonyl reductases in the rat ovary","volume":"230","author":"Aoki","year":"1996","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cbi.2026.112315_bib10","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/j.1432-1033.1995.tb20286.x","article-title":"Cloning and expression of carbonyl reductase from rat testis","volume":"228","author":"Wermuth","year":"1995","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.cbi.2026.112315_bib11","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1093\/oxfordjournals.jbchem.a122704","article-title":"The purification and properties of NADPH-dependent carbonyl reductases from rat ovary","volume":"105","author":"Iwata","year":"1989","journal-title":"J. Biochem."},{"key":"10.1016\/j.cbi.2026.112315_bib12","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1095\/biolreprod62.2.390","article-title":"Characterization of ovarian carbonyl reductase gene expression during ovulation in the gonadotropin-primed immature rat","volume":"62","author":"Espey","year":"2000","journal-title":"Biol. Reprod."},{"key":"10.1016\/j.cbi.2026.112315_bib13","doi-asserted-by":"crossref","first-page":"13451","DOI":"10.1016\/S0021-9258(18)42232-6","article-title":"Pig testicular 20\u03b2-hydroxysteroid dehydrogenase exhibits carbonyl reductase-like structure and activity. cDNA cloning of pig testicular 20\u03b2-hydroxysteroid dehydrogenase","volume":"267","author":"Tanaka","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cbi.2026.112315_bib14","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/0960-0760(91)90093-K","article-title":"20\u03b2-Hydroxysteroid dehydrogenase of neonatal pig testis: 3\u03b1\/\u03b2-hydroxysteroid dehydrogenase activities catalyzed by highly purified enzyme","volume":"38","author":"Ohno","year":"1991","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.cbi.2026.112315_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2023.110572","article-title":"Characterization of a novel porcine carbonyl reductase activated by glutathione: relationship to carbonyl reductase 1, 3\u03b1\/\u03b2-hydroxysteroid dehydrogenase and prostaglandin 9-ketoreductase","volume":"381","author":"Endo","year":"2023","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.cbi.2026.112315_bib16","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1677\/jme.1.02025","article-title":"Cloning and expression of chicken 20-hydroxysteroid dehydrogenase","volume":"37","author":"Bryndov\u00e1","year":"2006","journal-title":"J. Mol. Endocrinol."},{"key":"10.1016\/j.cbi.2026.112315_bib17","doi-asserted-by":"crossref","first-page":"3918","DOI":"10.1111\/febs.13385","article-title":"A novel NAD(P)H-dependent carbonyl reductase specifically expressed in the thyroidectomized chicken fatty liver: catalytic properties and crystal structure","volume":"282","author":"Fukuda","year":"2015","journal-title":"FEBS J."},{"key":"10.1016\/j.cbi.2026.112315_bib18","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1093\/oxfordjournals.jbchem.a134105","article-title":"Isolation of proteins with carbonyl reductase activity and prostaglandin-9-ketoreductase activity from chicken kidney","volume":"92","author":"Hara","year":"1982","journal-title":"J. Biochem."},{"key":"10.1016\/j.cbi.2026.112315_bib19","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1248\/bpb1978.14.413","article-title":"3-Keto reductase activity of estradiol-17\u03b2 dehydrogenase and its contribution to androgen metabolism","volume":"14","author":"Nishinaka","year":"1999","journal-title":"J. Pharmacobio-Dyn"},{"key":"10.1016\/j.cbi.2026.112315_bib20","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/0304-4165(86)90158-3","article-title":"Characterization of pulmonary carbonyl reductase of mouse and guinea pig","volume":"882","author":"Nakayama","year":"1986","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.cbi.2026.112315_bib21","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/0003-9861(92)90028-U","article-title":"Purification and characterization of pig lung carbonyl reductase","volume":"292","author":"Oritani","year":"1992","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.cbi.2026.112315_bib22","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1432-1033.1995.tb20274.x","article-title":"Cloning, expression and tissue distribution of mouse tetrameric carbonyl reductase. Identity with an adipocyte 27-kDa protein","volume":"228","author":"Nakanishi","year":"1995","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.cbi.2026.112315_bib23","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0969-2126(96)00007-X","article-title":"Crystal structure of the ternary complex of mouse lung carbonyl reductase at 1.8 \u00c5 resolution: the structural origin of coenzyme specificity in the short-chain dehydrogenase\/reductase family","volume":"4","author":"Tanaka","year":"1996","journal-title":"Structure"},{"key":"10.1016\/j.cbi.2026.112315_bib24","first-page":"335","article-title":"Pulmonary carbonyl reductase: metabolism of carbonyl products in lipid peroxidation","volume":"290","author":"Matsuura","year":"1989","journal-title":"Prog. Clin. Biol. Res."},{"key":"10.1016\/j.cbi.2026.112315_bib25","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1021\/tx800162p","article-title":"Carbonyl reductase inactivation may contribute to mouse lung tumor promotion by electrophilic metabolites of butylated hydroxytoluene: protein alkylation in vivo and in vitro","volume":"21","author":"Shearn","year":"2008","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.cbi.2026.112315_bib26","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1080\/019021401300053966","article-title":"Detection of differentially expressed genes in mouse lung adenocarcinomas","volume":"27","author":"Lin","year":"2001","journal-title":"Exp. Lung Res."},{"key":"10.1016\/j.cbi.2026.112315_bib27","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s11010-008-9794-5","article-title":"Different functions between human monomeric carbonyl reductase 3 and carbonyl reductase 1","volume":"315","author":"Miura","year":"2008","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.cbi.2026.112315_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0007113","article-title":"Structural basis for substrate specificity in human monomeric carbonyl reductases","volume":"4","author":"Pilka","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.cbi.2026.112315_bib29","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.cbi.2011.01.016","article-title":"Studies on reduction of S-nitrosoglutathione by human carbonyl reductases 1 and 3","volume":"191","author":"Staab","year":"2011","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.cbi.2026.112315_bib30","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.cbi.2008.11.004","article-title":"Analysis of the substrate-binding site of human carbonyl reductases CBR1 and CBR3 by site-directed mutagenesis","volume":"178","author":"El-Hawari","year":"2009","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.cbi.2026.112315_bib31","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1016\/j.bbrc.2008.11.003","article-title":"Human carbonyl reductase 4 is a mitochondrial NADPH-dependent quinone reductase","volume":"377","author":"Endo","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cbi.2026.112315_bib32","doi-asserted-by":"crossref","first-page":"4805","DOI":"10.1038\/ncomms5805","article-title":"Insights into mitochondrial fatty acid synthesis from the structure of heterotetrameric 3-ketoacyl-ACP reductase\/3R-hydroxyacyl-CoA dehydrogenase","volume":"5","author":"Venkatesan","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cbi.2026.112315_bib33","doi-asserted-by":"crossref","DOI":"10.1002\/ccs3.12041","article-title":"Hypoxia drives CBR4 down-regulation promotes gastroenteropancreatic neuroendocrine tumors via activation mammalian target of rapamycin mediated by fatty acid synthase","volume":"18","author":"Ye","year":"2024","journal-title":"J. Cell Commun. Signal."},{"key":"10.1016\/j.cbi.2026.112315_bib34","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/s12935-025-03776-0","article-title":"Carbonyl reductase 4 suppresses colorectal cancer progression through the DNMT3B\/CBR4\/FASN\/mTOR axis","volume":"25","author":"Zhang","year":"2025","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.cbi.2026.112315_bib35","doi-asserted-by":"crossref","first-page":"18457","DOI":"10.1074\/jbc.M100538200","article-title":"Porcine carbonyl reductase. structural basis for a functional monomer in short chain dehydrogenases\/reductases","volume":"276","author":"Ghosh","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cbi.2026.112315_bib36","doi-asserted-by":"crossref","first-page":"35756","DOI":"10.1074\/jbc.M807125200","article-title":"Human carbonyl reductase 1 is an S-nitrosoglutathione reductase","volume":"283","author":"Bateman","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cbi.2026.112315_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.0030128","article-title":"An unbiased cell morphology-based screen for new, biologically active small molecules","volume":"3","author":"Tanaka","year":"2005","journal-title":"PLoS Biol."},{"key":"10.1016\/j.cbi.2026.112315_bib38","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jsb.2015.09.005","article-title":"Structural insights on the catalytic site protection of human carbonyl reductase 1 by glutathione","volume":"192","author":"Liang","year":"2015","journal-title":"J. Struct. Biol."},{"key":"10.1016\/j.cbi.2026.112315_bib39","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1042\/bj2440165","article-title":"Kinetics of carbonyl reductase from human brain","volume":"244","author":"Bohren","year":"1987","journal-title":"Biochem. J."},{"key":"10.1016\/j.cbi.2026.112315_bib40","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1042\/bj3500089","article-title":"Mutation of threonine-241 to proline eliminates autocatalytic modification of human carbonyl reductase","volume":"350","author":"Sciotti","year":"2000","journal-title":"Biochem. J."},{"key":"10.1016\/j.cbi.2026.112315_bib41","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1006\/bbrc.1994.1681","article-title":"A novel 34 kDa glutathione-binding protein in mature rat ovary","volume":"201","author":"Toft","year":"1994","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cbi.2026.112315_bib42","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1042\/bj3170879","article-title":"Characterization of pig liver glutathione S-transferases using HPLC-electrospray-ionization mass spectrometry","volume":"317","author":"Rouimi","year":"1996","journal-title":"Biochem. J."},{"key":"10.1016\/j.cbi.2026.112315_bib43","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/0167-4838(95)00218-9","article-title":"The 30 kDa protein co-purified with chick liver glutathione S-transferases is a carbonyl reductase","volume":"1292","author":"Tsai","year":"1996","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.cbi.2026.112315_bib44","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1177\/40.12.1453004","article-title":"Immunohistochemical localization of carbonyl reductase in human tissues","volume":"40","author":"Wirth","year":"1992","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.cbi.2026.112315_bib45","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/j.xphs.2017.01.024","article-title":"Human tissue distribution of carbonyl reductase 1 using proteomic approach with liquid chromatography-tandem mass spectrometry","volume":"106","author":"Hua","year":"2017","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.cbi.2026.112315_bib46","doi-asserted-by":"crossref","DOI":"10.1126\/science.1260419","article-title":"Proteomics. Tissue-based map of the human proteome","volume":"347","author":"Uhl\u00e9n","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.cbi.2026.112315_bib47","doi-asserted-by":"crossref","first-page":"5947","DOI":"10.1126\/science.aay5947","article-title":"An atlas of the protein-coding genes in the human, pig, and mouse brain","volume":"367","author":"Sj\u00f6stedt","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.cbi.2026.112315_bib48","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1016\/S0021-9258(19)69950-3","article-title":"Purification and properties of an NADPH-dependent carbonyl reductase from human brain. Relationship to prostaglandin 9-ketoreductase and xenobiotic ketone reductase","volume":"256","author":"Wermuth","year":"1981","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cbi.2026.112315_bib49","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/j.1432-1033.1992.tb16952.x","article-title":"Purification and properties of prostaglandin 9-ketoreductase from pig and human kidney. Identity with human carbonyl reductase","volume":"206","author":"Schieber","year":"1992","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.cbi.2026.112315_bib50","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1046\/j.1365-2443.2000.00310.x","article-title":"Close kinship of human 20\u03b1-hydroxysteroid dehydrogenase gene with three aldo-keto reductase genes","volume":"5","author":"Nishizawa","year":"2000","journal-title":"Genes Cells"},{"key":"10.1016\/j.cbi.2026.112315_bib51","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/0304-4165(92)90127-G","article-title":"Carbonyl reductase from human testis: purification and comparison with carbonyl reductase from human brain and rat testis","volume":"1116","author":"Inazu","year":"1992","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.cbi.2026.112315_bib52","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.freeradbiomed.2015.02.001","article-title":"NADP+-dependent dehydrogenase activity of carbonyl reductase on glutathionyl hydroxynonanal as a new pathway for hydroxynonenal detoxification","volume":"83","author":"Moschini","year":"2015","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.cbi.2026.112315_bib53","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/0090-6980(83)90149-1","article-title":"Substrate specificity of three prostaglandin dehydrogenases","volume":"26","author":"Jarabak","year":"1983","journal-title":"Prostaglandins"},{"key":"10.1016\/j.cbi.2026.112315_bib54","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1124\/pharmrev.123.000901","article-title":"Prostaglandin E2 in the tumor microenvironment, a convoluted affair mediated by EP receptors 2 and 4","volume":"76","author":"Santiso","year":"2024","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.cbi.2026.112315_bib55","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.3109\/10715762.2010.498477","article-title":"Chemistry and biochemistry of lipid peroxidation products","volume":"44","author":"Gu\u00e9raud","year":"2010","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.cbi.2026.112315_bib56","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.cbi.2014.12.028","article-title":"Oxidative and reductive metabolism of lipid-peroxidation derived carbonyls","volume":"234","author":"Singh","year":"2015","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.cbi.2026.112315_bib57","doi-asserted-by":"crossref","first-page":"13106","DOI":"10.1021\/bi049136q","article-title":"Human carbonyl reductase catalyzes reduction of 4-oxonon-2-enal","volume":"43","author":"Doorn","year":"2004","journal-title":"Biochemistry"},{"key":"10.1016\/j.cbi.2026.112315_bib58","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.freeradbiomed.2016.08.015","article-title":"Human carbonyl reductase 1 as efficient catalyst for the reduction of glutathionylated aldehydes derived from lipid peroxidation","volume":"99","author":"Rotondo","year":"2016","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.cbi.2026.112315_bib59","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.cbi.2017.03.003","article-title":"Kinetic features of carbonyl reductase 1 acting on glutathionylated aldehydes","volume":"276","author":"Moschini","year":"2017","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.cbi.2026.112315_bib60","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.bbrc.2019.11.090","article-title":"Dehydrogenase\/reductase activity of human carbonyl reductase 1 with NADP(H) acting as a prosthetic group","volume":"522","author":"Barracco","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cbi.2026.112315_bib200","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1021\/tx0300378","article-title":"Aldose reductase catalyzes reduction of the lipid peroxidation product 4-oxonon-2-enal","volume":"16","author":"Doorn","year":"2003","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.cbi.2026.112315_bib201","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.3109\/10715762.2014.957694","article-title":"Nitric oxide confers cisplatin resistance in human lung cancer cells through upregulation of aldo-keto reductase 1B10 and proteasome","volume":"48","author":"Matsunaga","year":"2014","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.cbi.2026.112315_bib202","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.cbi.2011.02.004","article-title":"Human aldo-keto reductases 1B1 and 1B10: a comparative study on their enzyme activity toward electrophilic carbonyl compounds","volume":"191","author":"Shen","year":"2011","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.cbi.2026.112315_bib61","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.mam.2008.05.005","article-title":"Regulation of glutathione synthesis","volume":"30","author":"Lu","year":"2009","journal-title":"Mol. Aspect. Med."},{"key":"10.1016\/j.cbi.2026.112315_bib62","doi-asserted-by":"crossref","first-page":"671","DOI":"10.2174\/011570159X342720241014164650","article-title":"Oxidative stress-mediated lipid peroxidation-derived lipid aldehydes in the pathophysiology of neurodegenerative diseases","volume":"23","author":"Allowitz","year":"2025","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.cbi.2026.112315_bib63","doi-asserted-by":"crossref","first-page":"4214","DOI":"10.1158\/0008-5472.CAN-12-1110","article-title":"Carbonyl reductase 1 offers a novel therapeutic target to enhance leukemia treatment by arsenic trioxide","volume":"72","author":"Jang","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.cbi.2026.112315_bib64","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1016\/j.biocel.2013.05.025","article-title":"Carbonyl reductase 1 is an essential regulator of skeletal muscle differentiation and regeneration","volume":"45","author":"Lim","year":"2013","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.cbi.2026.112315_bib65","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.freeradbiomed.2014.01.006","article-title":"Neuroprotective effects of PEP-1-carbonyl reductase 1 against oxidative-stress-induced ischemic neuronal cell damage","volume":"69","author":"Kim","year":"2014","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.cbi.2026.112315_bib66","doi-asserted-by":"crossref","first-page":"5303","DOI":"10.3892\/ol.2016.5339","article-title":"RACK1 promotes hepatocellular carcinoma cell survival via CBR1 by suppressing TNF-\u03b1-induced ROS generation","volume":"12","author":"Zhou","year":"2016","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.cbi.2026.112315_bib67","first-page":"672","article-title":"Upregulation of carbonyl reductase 1 by Nrf2 as a potential therapeutic intervention for ischemia\/reperfusion injury during liver transplantation","volume":"42","author":"Kwon","year":"2019","journal-title":"Mol. Cells"},{"key":"10.1016\/j.cbi.2026.112315_bib68","doi-asserted-by":"crossref","first-page":"533","DOI":"10.7150\/jca.34303","article-title":"Inhibition of carbonyl reductase 1 enhances metastasis of head and neck squamous cell carcinoma through \u03b2-catenin-mediated epithelial-mesenchymal transition","volume":"11","author":"Yun","year":"2020","journal-title":"J. Cancer"},{"key":"10.1016\/j.cbi.2026.112315_bib69","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s12975-021-00912-6","article-title":"Carbonyl reductase 1 attenuates ischemic brain injury by reducing oxidative stress and neuroinflammation","volume":"12","author":"Mao","year":"2021","journal-title":"Transl. Stroke Res"},{"key":"10.1016\/j.cbi.2026.112315_bib70","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2024.106574","article-title":"Involvement of porcine and human carbonyl reductases in the metabolism of epiandrosterone, 11-oxygenated steroids, neurosteroids, and corticosteroids","volume":"243","author":"Endo","year":"2024","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.cbi.2026.112315_bib71","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.steroids.2013.10.012","article-title":"Role of aldo-keto reductase family 1 (AKR1) enzymes in human steroid metabolism","volume":"79","author":"Ri\u017ener","year":"2014","journal-title":"Steroids"},{"key":"10.1016\/j.cbi.2026.112315_bib72","doi-asserted-by":"crossref","DOI":"10.1111\/jne.12351","article-title":"Neurosteroidogenesis today: novel targets for neuroactive steroid synthesis and action and their relevance for translational research","volume":"28","author":"Porcu","year":"2016","journal-title":"J. Neuroendocrinol."},{"key":"10.1016\/j.cbi.2026.112315_bib73","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-10410-1","article-title":"Carbonyl reductase 1 catalyzes 20\u03b2-reduction of glucocorticoids, modulating receptor activation and metabolic complications of obesity","volume":"7","author":"Morgan","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cbi.2026.112315_bib74","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.cbi.2011.01.019","article-title":"Activities of aldo-keto reductase 1 enzymes on two inhaled corticosteroids: implications for the pharmacological effects of inhaled corticosteroids","volume":"91","author":"Jin","year":"2011","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.cbi.2026.112315_bib75","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/0006-291X(91)91628-P","article-title":"Human carbonyl and aldose reductases: new catalytic functions in tetrahydrobiopterin biosynthesis","volume":"175","author":"Park","year":"1991","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cbi.2026.112315_bib76","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1042\/BJ20110293","article-title":"Tetrahydrobiopterin: biochemistry and pathophysiology","volume":"438","author":"Werner","year":"2011","journal-title":"Biochem. J."},{"key":"10.1016\/j.cbi.2026.112315_bib77","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1173599","article-title":"Peripheralized sepiapterin reductase inhibition as a safe analgesic therapy","volume":"14","author":"Cronin","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.cbi.2026.112315_bib78","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1016\/j.bbagen.2013.02.004","volume":"1830","author":"Broniowska","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.cbi.2026.112315_bib79","doi-asserted-by":"crossref","first-page":"19180","DOI":"10.1074\/jbc.271.32.19180","article-title":"S-nitrosoglutathione is cleaved by the thioredoxin system with liberation of glutathione and redox regulating nitric oxide","volume":"271","author":"Nikitovic","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cbi.2026.112315_bib80","doi-asserted-by":"crossref","first-page":"18285","DOI":"10.1074\/jbc.RA119.011067","article-title":"AKR1A1 is a novel mammalian S-nitrosoglutathione reductase","volume":"294","author":"Stomberski","year":"2019","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cbi.2026.112315_bib81","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.freeradbiomed.2017.05.014","article-title":"Chronicles of a reductase: biochemistry, genetics and physio-pathological role of GSNOR","volume":"110","author":"Rizza","year":"2017","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.cbi.2026.112315_bib82","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/biof.1408","article-title":"Isatin, an endogenous nonpeptide biofactor: a review of its molecular targets, mechanisms of actions, and their biomedical implications","volume":"44","author":"Medvedev","year":"2018","journal-title":"Biofactors"},{"key":"10.1016\/j.cbi.2026.112315_bib83","doi-asserted-by":"crossref","DOI":"10.3389\/fnbeh.2022.922274","article-title":"Tryptophan metabolites as mediators of microbiota-gut-brain communication: focus on isatin","volume":"16","author":"Medvedev","year":"2022","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.cbi.2026.112315_bib84","doi-asserted-by":"crossref","first-page":"5755","DOI":"10.1046\/j.0014-2956.2001.02510.x","article-title":"Characterization of a major form of human isatin reductase and the reduced metabolite","volume":"268","author":"Usami","year":"2001","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.cbi.2026.112315_bib85","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.abb.2008.06.002","article-title":"Characterization of human DHRS4: an inducible short-chain dehydrogenase\/reductase enzyme with 3\u03b2-hydroxysteroid dehydrogenase activity","volume":"477","author":"Matsunaga","year":"2008","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.cbi.2026.112315_bib86","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.abb.2009.05.009","article-title":"Kinetic studies of AKR1B10, human aldose reductase-like protein: endogenous substrates and inhibition by steroids","volume":"487","author":"Endo","year":"2009","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.cbi.2026.112315_bib87","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.cbi.2016.09.001","article-title":"In vitro metabolism of fenofibric acid by carbonyl reducing enzymes","volume":"258","author":"Mal\u00e1tkov\u00e1","year":"2016","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.cbi.2026.112315_bib88","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1124\/dmd.117.075929","article-title":"Stereospecific metabolism of R- and S-warfarin by human hepatic cytosolic reductases","volume":"45","author":"Barnette","year":"2017","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.cbi.2026.112315_bib89","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.cbi.2017.03.006","article-title":"Reductive metabolism of tiaprofenic acid by the human liver and recombinant carbonyl reducing enzymes","volume":"276","author":"Mal\u00e1tkov\u00e1","year":"2017","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.cbi.2026.112315_bib90","doi-asserted-by":"crossref","DOI":"10.1016\/j.dmd.2026.100278","article-title":"Ketone reduction drives major circulating metabolites of GDC-8264 in humans","volume":"54","author":"Wang","year":"2026","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.cbi.2026.112315_bib91","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1124\/dmd.122.001037","article-title":"Quantitative evaluation of the contribution of each aldo-keto reductase and short-chain dehydrogenase\/reductase isoform to reduction reactions of compounds containing a ketone group in the human liver","volume":"51","author":"Ichida","year":"2023","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.cbi.2026.112315_bib92","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1124\/dmd.123.001402","article-title":"Quantitative analysis of mRNA and protein expression levels of aldo-keto reductase and short-chain dehydrogenase\/reductase isoforms in the human intestine","volume":"51","author":"Hirosawa","year":"2023","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.cbi.2026.112315_bib93","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s10637-017-0443-2","article-title":"Metabolic carbonyl reduction of anthracyclines - role in cardiotoxicity and cancer resistance. Reducing enzymes as putative targets for novel cardioprotective and chemosensitizing agents","volume":"35","author":"Piska","year":"2017","journal-title":"Invest. N. Drugs"},{"key":"10.1016\/j.cbi.2026.112315_bib94","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0006-2952(95)00124-I","article-title":"Reduction of drug ketones by dihydrodiol dehydrogenases, carbonyl reductase and aldehyde reductase of human liver","volume":"50","author":"Ohara","year":"1995","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.cbi.2026.112315_bib95","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0167-4781(90)90050-C","article-title":"Induction of a human carbonyl reductase gene located on chromosome 21","volume":"1048","author":"Forrest","year":"1990","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.cbi.2026.112315_bib96","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.freeradbiomed.2009.07.035","article-title":"Nrf2:INrf2 (Keap1) signaling in oxidative stress","volume":"47","author":"Kaspar","year":"2009","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.cbi.2026.112315_bib97","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.cbi.2012.11.023","article-title":"Regulation of human carbonyl reductase 1 (CBR1, SDR21C1) gene by transcription factor Nrf2","volume":"202","author":"Miura","year":"2013","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.cbi.2026.112315_bib98","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.3389\/fimmu.2020.01488","article-title":"Hydroxyurea scavenges free radicals and induces the expression of antioxidant genes in human cell cultures treated with hemin","volume":"11","author":"Santana","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cbi.2026.112315_bib99","doi-asserted-by":"crossref","first-page":"184","DOI":"10.3390\/medsci13030184","article-title":"Proteome differences in smooth muscle cells from diabetic and non-diabetic abdominal aortic aneurysm patients reveal metformin-induced mechanisms","volume":"13","author":"van Merrienboer","year":"2025","journal-title":"Med. Sci."},{"issue":"1","key":"10.1016\/j.cbi.2026.112315_bib100","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1038\/s42003-025-08564-0","article-title":"Vitamin K2 inhibits PGE2-mediated osteoblast ferroptosis by upregulation of CBR1 via the Nrf2\/Keap1 pathway","volume":"8","author":"Tao","year":"2025","journal-title":"Commun. Biol."},{"key":"10.1016\/j.cbi.2026.112315_bib101","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3389\/fphar.2020.00097","article-title":"Maternal 25-hydroxyvitamin D deficiency promoted metabolic syndrome and downregulated Nrf2\/CBR1 pathway in offspring","volume":"11","author":"Zheng","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.cbi.2026.112315_bib102","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1080\/09513590.2021.1942451","article-title":"Maternal, umbilical arterial metabolic levels and placental Nrf2\/CBR1 expression in pregnancies with and without 25-hydroxyvitamin D deficiency","volume":"37","author":"Chen","year":"2021","journal-title":"Gynecol. Endocrinol."},{"key":"10.1016\/j.cbi.2026.112315_bib103","doi-asserted-by":"crossref","first-page":"533","DOI":"10.3390\/nu15030533","article-title":"The role of maternal vitamin D deficiency in offspring obesity: a narrative review","volume":"15","author":"Wu","year":"2023","journal-title":"Nutrients"},{"key":"10.1016\/j.cbi.2026.112315_bib104","article-title":"A quantitative proteomic approach to evaluate the efficacy of carnosine in a murine model of chronic obstructive pulmonary disease (COPD)","volume":"77","author":"D'Amato","year":"2024","journal-title":"Redox Biol."},{"issue":"18","key":"10.1016\/j.cbi.2026.112315_bib105","first-page":"5196","article-title":"Identification of Nrf2-regulated genes induced by the chemopreventive agent sulforaphane by oligonucleotide microarray","volume":"62","author":"Thimmulappa","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.cbi.2026.112315_bib106","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2025.107862","article-title":"Nuclear receptors in metabolism and diseases: mechanistic and therapeutic insights","volume":"218","author":"Zhu","year":"2025","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.cbi.2026.112315_bib107","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1124\/mol.107.035550","article-title":"Functional characterization of the promoter of human carbonyl reductase 1 (CBR1). Role of XRE elements in mediating the induction of CBR1 by ligands of the aryl hydrocarbon receptor","volume":"72","author":"Lakhman","year":"2007","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.cbi.2026.112315_bib108","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.toxlet.2012.04.006","article-title":"Induction of carbonyl reductase 1 (CBR1) expression in human lung tissues and lung cancer cells by the cigarette smoke constituent benzo[a]pyrene","volume":"211","author":"Kalabus","year":"2012","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.cbi.2026.112315_bib109","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1210\/en.2013-1848","article-title":"Induction of PGF2\u03b1 synthesis by cortisol through GR dependent induction of CBR1 in human amnion fibroblasts","volume":"155","author":"Guo","year":"2014","journal-title":"Endocrinology"},{"key":"10.1016\/j.cbi.2026.112315_bib110","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1158\/1535-7163.MCT-06-0722","article-title":"Clofibric acid, a peroxisome proliferator-activated receptor \u03b1 ligand, inhibits growth of human ovarian cancer","volume":"6","author":"Yokoyama","year":"2007","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.cbi.2026.112315_bib111","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.jhep.2010.06.045","article-title":"Human carbonyl reductase 1 upregulated by hypoxia renders resistance to apoptosis in hepatocellular carcinoma cells","volume":"54","author":"Tak","year":"2011","journal-title":"J. Hepatol."},{"key":"10.1016\/j.cbi.2026.112315_bib112","doi-asserted-by":"crossref","first-page":"122","DOI":"10.3177\/jnsv.60.122","article-title":"Resveratrol reduces the hypoxia-induced resistance to doxorubicin in breast cancer cells","volume":"60","author":"Mitani","year":"2014","journal-title":"J. Nutr. Sci. Vitaminol. (Tokyo)"},{"key":"10.1016\/j.cbi.2026.112315_bib113","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.canlet.2020.12.020","article-title":"Metabolic adaptation in hypoxia and cancer","volume":"502","author":"Paredes","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.cbi.2026.112315_bib114","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0048622","article-title":"MicroRNAs differentially regulate carbonyl reductase 1 (CBR1) gene expression dependent on the allele status of the common polymorphic variant rs9024","volume":"7","author":"Kalabus","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.cbi.2026.112315_bib115","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1097\/CAD.0000000000001385","article-title":"LncRNA MYMLR promotes pituitary adenoma development by upregulating carbonyl reductase 1 via sponging miR-197-3p","volume":"33","author":"Wang","year":"2022","journal-title":"Anti Cancer Drugs"},{"key":"10.1016\/j.cbi.2026.112315_bib116","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s00335-025-10177-1","article-title":"E2F2 inhibits hippocampal neurogenesis in poststroke depression rats via the miR-1290\/CBR1 axis","volume":"37","author":"Yang","year":"2025","journal-title":"Mamm. Genome"},{"key":"10.1016\/j.cbi.2026.112315_bib117","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41392-020-00450-x","article-title":"The role of m6A modification in the biological functions and diseases","volume":"6","author":"Jiang","year":"2021","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.cbi.2026.112315_bib118","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1016\/j.cmet.2024.08.006","article-title":"m6A mRNA methylation in brown fat regulates systemic insulin sensitivity via an inter-organ prostaglandin signaling axis independent of UCP1","volume":"36","author":"Xiao","year":"2024","journal-title":"Cell Metab."},{"key":"10.1016\/j.cbi.2026.112315_bib119","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2025.115072","article-title":"IGF2BP2 regulates inflammation in ulcerative colitis through N6-methyladenosine-dependent modulation of CBR1","volume":"161","author":"Wu","year":"2025","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.cbi.2026.112315_bib120","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.placenta.2024.10.018","article-title":"Epigenetic effects of exercise on improving the adverse placental environment associated with maternal overweight and obesity","volume":"158","author":"Wang","year":"2024","journal-title":"Placenta"},{"key":"10.1016\/j.cbi.2026.112315_bib121","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1054\/bjoc.2001.2034","article-title":"Carbonyl reductase as a significant predictor of survival and lymph node metastasis in epithelial ovarian cancer","volume":"85","author":"Umemoto","year":"2001","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.cbi.2026.112315_bib126","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.canlet.2011.06.036","article-title":"Suppression of carbonyl reductase expression enhances malignant behaviour in uterine cervical squamous cell carcinoma: carbonyl reductase predicts prognosis and lymph node metastasis","volume":"311","author":"Murakami","year":"2011","journal-title":"Cancer Lett."},{"key":"10.1016\/j.cbi.2026.112315_bib128","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.canlet.2012.03.035","article-title":"Decreased carbonyl reductase 1 expression promotes malignant behaviours by induction of epithelial mesenchymal transition and its clinical significance","volume":"323","author":"Murakami","year":"2012","journal-title":"Cancer Lett."},{"key":"10.1016\/j.cbi.2026.112315_bib131","first-page":"400","article-title":"Low carbonyl reductase 1 expression is associated with poor prognosis in patients with oral squamous cell carcinoma","volume":"8","author":"Yamanouchi","year":"2018","journal-title":"Mol. Clin. Oncol."},{"key":"10.1016\/j.cbi.2026.112315_bib132","first-page":"1173","article-title":"Carbonyl reductase: a novel metastasis-modulating function","volume":"60","author":"Ismail","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.cbi.2026.112315_bib135","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114813","article-title":"Chrysin induces autophagy-dependent ferroptosis to increase chemosensitivity to gemcitabine by targeting CBR1 in pancreatic cancer cells","volume":"193","author":"Zhou","year":"2021","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.cbi.2026.112315_bib137","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1042\/bj3280473","article-title":"Characterization of S-hexylglutathione-binding proteins of human hepatocellular carcinoma: separation of enoyl-CoA isomerase from an Alpha class glutathione transferase form","volume":"328","author":"Kajihara-Kano","year":"1997","journal-title":"Biochem. J."},{"key":"10.1016\/j.cbi.2026.112315_bib140","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1631\/jzus.B2400509","article-title":"Depleting CBR1 increases chemosensitivity by reducing stemness and quiescence traits in non-small cell lung cancer","volume":"26","author":"Li","year":"2025","journal-title":"J. Zhejiang Univ. - Sci. B."},{"key":"10.1016\/j.cbi.2026.112315_bib141","first-page":"5394","article-title":"Integrative analysis of CBR1 as a prognostic factor associated with IDH-mutant glioblastoma in the Chinese population","volume":"14","author":"Ji","year":"2022","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.cbi.2026.112315_bib138","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/ijc.2910450304","article-title":"Cytosolic NAD(P)H:(quinone-acceptor) oxidoreductase in human normal and tumor tissue: effects of cigarette smoking and alcohol","volume":"45","author":"Schlager","year":"1990","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.cbi.2026.112315_bib143","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2025.1540992","article-title":"The joint role of the immune microenvironment and N7-methylguanosine for prognosis prediction and targeted therapy in acute myeloid leukemia","volume":"16","author":"Chen","year":"2025","journal-title":"Front. Genet."},{"key":"10.1016\/j.cbi.2026.112315_bib144","doi-asserted-by":"crossref","first-page":"4707","DOI":"10.7150\/jca.31234","article-title":"Expression profile analysis of prognostic long non-coding RNA in adult acute myeloid leukemia by weighted gene co-expression network analysis (WGCNA)","volume":"10","author":"Chen","year":"2019","journal-title":"J. Cancer"},{"key":"10.1016\/j.cbi.2026.112315_bib122","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.3892\/ijo.2014.2810","article-title":"Decreased expression of carbonyl reductase 1 promotes ovarian cancer growth and proliferation","volume":"46","author":"Osawa","year":"2015","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.cbi.2026.112315_bib123","doi-asserted-by":"crossref","first-page":"359","DOI":"10.3892\/ol.2024.14492","article-title":"Overexpression of carbonyl reductase 1 in ovarian cancer cells suppresses proliferation and activates the eIF2 signaling pathway","volume":"28","author":"Kadonosawa","year":"2024","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.cbi.2026.112315_bib127","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/rmb2.12086","article-title":"Decreased carbonyl reductase 1 expression promotes tumor growth via epithelial mesenchymal transition in uterine cervical squamous cell carcinomas","volume":"17","author":"Nishimoto","year":"2018","journal-title":"Reprod. Med. Biol."},{"key":"10.1016\/j.cbi.2026.112315_bib129","first-page":"1503","article-title":"Overexpression of carbonyl reductase 1 inhibits malignant behaviors and epithelial mesenchymal transition by suppressing TGF-\u03b2 signaling in uterine leiomyosarcoma cells","volume":"18","author":"Kajimura","year":"2019","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.cbi.2026.112315_bib124","doi-asserted-by":"crossref","first-page":"107","DOI":"10.4137\/CMO.S9005","article-title":"Malignant ovarian tumors with induced expression of carbonyl reductase show spontaneous regression","volume":"6","author":"Wang","year":"2012","journal-title":"Clin. Med. Insights Oncol."},{"key":"10.1016\/j.cbi.2026.112315_bib125","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.3892\/ijo.2015.3205","article-title":"Inhibitory effect of carbonyl reductase 1 on ovarian cancer growth via tumor necrosis factor receptor signaling","volume":"47","author":"Miura","year":"2015","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.cbi.2026.112315_bib130","doi-asserted-by":"crossref","first-page":"591","DOI":"10.21873\/cgp.20344","article-title":"Prognostic significance of the BIRC2-BIRC3 gene signature in head and neck squamous cell carcinoma","volume":"19","author":"Lee","year":"2022","journal-title":"Cancer Genomics Proteomics"},{"key":"10.1016\/j.cbi.2026.112315_bib133","doi-asserted-by":"crossref","DOI":"10.1177\/15330338251408321","article-title":"Molecular drivers of prostate cancer metastasis: emerging targets for precision therapy","volume":"25","author":"Iweala","year":"2026","journal-title":"Technol. Cancer Res. Treat."},{"key":"10.1016\/j.cbi.2026.112315_bib134","first-page":"590","article-title":"Prostanoid signaling in cancers: expression and regulation patterns of enzymes and receptors","volume":"11","author":"Ershov","year":"2022","journal-title":"Biology (Basel)"},{"key":"10.1016\/j.cbi.2026.112315_bib136","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s004320050246","article-title":"Decreased expression of the peroxisomal bifunctional enzyme and carbonyl reductase in human hepatocellular carcinomas","volume":"125","author":"Suto","year":"1999","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.cbi.2026.112315_bib139","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0959-8049(98)00372-4","article-title":"Carbonyl reductase and NADPH cytochrome P450 reductase activities in human tumoral versus normal tissues","volume":"35","author":"L\u00f3pez de Cerain","year":"1999","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.cbi.2026.112315_bib142","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1038\/s41598-018-20179-6","article-title":"Curcumin targets multiple enzymes involved in the ROS metabolic pathway to suppress tumor cell growth","volume":"8","author":"Larasati","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cbi.2026.112315_bib145","article-title":"The role of cytochromes p450 and aldo-keto reductases in prognosis of breast carcinoma patients","volume":"93","author":"Hlav\u00e1\u010d","year":"2014","journal-title":"Medicine (Baltim.)"},{"key":"10.1016\/j.cbi.2026.112315_bib146","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2020.105511","article-title":"Cinnamic acid derivatives as chemosensitising agents against DOX-treated lung cancer cells - Involvement of carbonyl reductase 1","volume":"154","author":"Koczurkiewicz-Adamczyk","year":"2020","journal-title":"Eur. J. Pharmaceut. Sci."},{"key":"10.1016\/j.cbi.2026.112315_bib147","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1089\/ars.2015.6457","article-title":"Inhibition of carbonyl reductase 1 safely improves the efficacy of doxorubicin in breast cancer treatment","volume":"26","author":"Jo","year":"2017","journal-title":"Antioxid. Redox Signal"},{"key":"10.1016\/j.cbi.2026.112315_bib148","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1248\/bpb.b15-00176","article-title":"Up-regulation of carbonyl reductase 1 renders development of doxorubicin resistance in human gastrointestinal cancers","volume":"38","author":"Matsunaga","year":"2015","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.cbi.2026.112315_bib149","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/hep.23723","article-title":"Carbonyl reductase 1 as a novel target of (-)-epigallocatechin gallate against hepatocellular carcinoma","volume":"52","author":"Huang","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.cbi.2026.112315_bib150","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1007\/s00228-012-1291-9","article-title":"Carbonyl reductase 1 expression influences daunorubicin metabolism in acute myeloid leukemia","volume":"68","author":"Varatharajan","year":"2012","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.cbi.2026.112315_bib151","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s12032-025-02893-0","article-title":"Various anthracyclines exhibit differential cytotoxic effects related to CBR1-induced resistance in lung cancer cells","volume":"42","author":"Piska","year":"2025","journal-title":"Med. Oncol."},{"key":"10.1016\/j.cbi.2026.112315_bib152","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3164\/jcbn.14-10","article-title":"The role of lipid peroxidation in neurological disorders","volume":"54","author":"Shichiri","year":"2014","journal-title":"J. Clin. Biochem. Nutr."},{"key":"10.1016\/j.cbi.2026.112315_bib153","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.bbrc.2005.12.113","article-title":"Neuroprotective role for carbonyl reductase?","volume":"340","author":"Maser","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cbi.2026.112315_bib154","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/978-3-319-28383-8_19","article-title":"Detoxification of carbonyl compounds by carbonyl reductase in neurodegeneration","volume":"12","author":"Rashid","year":"2016","journal-title":"Adv. Neurobiol."},{"key":"10.1016\/j.cbi.2026.112315_bib155","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jprot.2015.04.005","article-title":"Redox proteomics identification of specifically carbonylated proteins in the hippocampi of triple transgenic Alzheimer's disease mice at its earliest pathological stage","volume":"123","author":"Shen","year":"2015","journal-title":"J. Proteomics"},{"key":"10.1016\/j.cbi.2026.112315_bib156","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.nbd.2007.12.007","article-title":"Redox proteomic identification of 4-hydroxy-2-nonenal-modified brain proteins in amnestic mild cognitive impairment: insight into the role of lipid peroxidation in the progression and pathogenesis of Alzheimer's disease","volume":"30","author":"Reed","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.cbi.2026.112315_bib157","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s40478-025-01958-5","article-title":"Proximity proteomics reveals unique and shared pathological features between multiple system atrophy and Parkinson's disease","volume":"13","author":"Choi","year":"2025","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.cbi.2026.112315_bib158","doi-asserted-by":"crossref","first-page":"5999","DOI":"10.3390\/ijms22115999","article-title":"The catecholaldehyde hypothesis for the pathogenesis of catecholaminergic neurodegeneration: what we know and what we do not know","volume":"22","author":"Goldstein","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cbi.2026.112315_bib159","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.freeradbiomed.2017.07.004","article-title":"Low molar excess of 4-oxo-2-nonenal and 4-hydroxy-2-nonenal promote oligomerization of \u03b1-synuclein through different pathways","volume":"110","author":"Almandoz-Gil","year":"2017","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.cbi.2026.112315_bib160","doi-asserted-by":"crossref","first-page":"3644","DOI":"10.1021\/acs.biochem.1c00478","article-title":"Lipid peroxidation products HNE and ONE promote and stabilize \u03b1-synuclein oligomers by chemical modifications","volume":"60","author":"Andersen","year":"2021","journal-title":"Biochemistry"},{"key":"10.1016\/j.cbi.2026.112315_bib161","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2026.104060","article-title":"Are glutathionylated aldehyde reductases the missing piece of the \"catecholaldehyde hypothesis\" in Parkinson's disease? A medical hypothesis concerning the detoxification of 4-hydroxynonenal (HNE) and 3,4-dihydroxyphenylacetaldehyde (DOPAL)","volume":"90","author":"Rotondo","year":"2026","journal-title":"Redox Biol."},{"key":"10.1016\/j.cbi.2026.112315_bib162","first-page":"193","article-title":"Increased brain protein levels of carbonyl reductase and alcohol dehydrogenase in Down syndrome and Alzheimer's disease","volume":"61","author":"Balcz","year":"2001","journal-title":"J. Neural. Transm. Suppl."},{"key":"10.1016\/j.cbi.2026.112315_bib163","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1590\/1414-431X20143792","article-title":"Bioinformatics analysis of biomarkers and transcriptional factor motifs in Down syndrome","volume":"47","author":"Kong","year":"2014","journal-title":"Braz. J. Med. Biol. Res."},{"key":"10.1016\/j.cbi.2026.112315_bib164","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-71085-9","article-title":"Impairment of spatial memory accuracy improved by Cbr1 copy number resumption and GABAB receptor-dependent enhancement of synaptic inhibition in Down syndrome model mice","volume":"10","author":"Arima-Yoshida","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cbi.2026.112315_bib165","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1042\/BSR20241636","article-title":"Carbonyl reductase 1: a novel regulator of blood pressure in Down syndrome","volume":"45","author":"Malbon","year":"2025","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.cbi.2026.112315_bib166","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1016\/j.freeradbiomed.2010.08.015","article-title":"Carbonyl reductase 1 protects pancreatic \u03b2-cells against oxidative stress-induced apoptosis in glucotoxicity and glucolipotoxicity","volume":"49","author":"Rashid","year":"2010","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.cbi.2026.112315_bib167","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1021\/acs.jproteome.8b00276","article-title":"Proteomics of the rat myocardium during development of type 2 diabetes mellitus reveals progressive alterations in major metabolic pathways","volume":"17","author":"Edhager","year":"2018","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.cbi.2026.112315_bib168","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.3390\/biomedicines13082006","article-title":"Identification of novel lactylation-related biomarkers for COPD diagnosis through machine learning and experimental validation","volume":"13","author":"Hu","year":"2025","journal-title":"Biomedicines"},{"key":"10.1016\/j.cbi.2026.112315_bib169","doi-asserted-by":"crossref","first-page":"520","DOI":"10.3109\/03602532.2015.1089885","article-title":"The modulation of carbonyl reductase 1 by polyphenols","volume":"47","author":"Bou\u0161ov\u00e1","year":"2015","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.cbi.2026.112315_bib170","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.cbi.2019.02.031","article-title":"Potent inhibition of human carbonyl reductase 1 (CBR1) by the prenylated chalconoid xanthohumol and its related prenylflavonoids isoxanthohumol and 8-prenylnaringenin","volume":"305","author":"Seliger","year":"2019","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.cbi.2026.112315_bib171","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.bcp.2017.04.023","article-title":"Human carbonyl reductase 1 participating in intestinal first-pass drug metabolism is inhibited by fatty acids and acyl-CoAs","volume":"138","author":"Hara","year":"2017","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.cbi.2026.112315_bib172","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120777","article-title":"Cinnamamide derivatives with 4-hydroxypiperidine moiety enhance effect of doxorubicin to cancer cells and protect cardiomyocytes against drug-induced toxicity through CBR1 inhibition mechanism","volume":"305","author":"Koczurkiewicz-Adamczyk","year":"2022","journal-title":"Life Sci."},{"key":"10.1016\/j.cbi.2026.112315_bib173","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2022.109823","article-title":"Inhibition of human carbonyl reducing enzymes by plant anthrone and anthraquinone derivatives","volume":"354","author":"Westermann","year":"2022","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.cbi.2026.112315_bib174","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2020.113118","article-title":"The epigallocatechin gallate derivative Y6 reduces the cardiotoxicity and enhances the efficacy of daunorubicin against human hepatocellular carcinoma by inhibiting carbonyl reductase 1 expression","volume":"261","author":"Zhou","year":"2020","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.cbi.2026.112315_bib175","doi-asserted-by":"crossref","first-page":"5690","DOI":"10.1111\/bph.12995","article-title":"Protective effect of 23-hydroxybetulinic acid on doxorubicin-induced cardiotoxicity: a correlation with the inhibition of carbonyl reductase-mediated metabolism","volume":"172","author":"Zhou","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.cbi.2026.112315_bib176","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e26701","article-title":"Revisiting luteolin: an updated review on its anticancer potential","volume":"10","author":"Rauf","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.cbi.2026.112315_bib177","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.175242","article-title":"Bergapten attenuates microglia-mediated neuroinflammation and ischemic brain injury by targeting Kv1.3 and Carbonyl reductase 1","volume":"933","author":"Gao","year":"2022","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.cbi.2026.112315_bib178","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2025.117313","article-title":"SuHeXiang Wan in the treatment of stroke: prediction potentially active metabolites using a combination of in silico analysis and experimental viability assessment","volume":"270","author":"Shen","year":"2026","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.cbi.2026.112315_bib179","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1124\/dmd.108.024547","article-title":"Pharmacogenetics of human carbonyl reductase 1 (CBR1) in livers from black and white donors","volume":"37","author":"Gonzalez-Covarrubias","year":"2009","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.cbi.2026.112315_bib180","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/bdd.2135","article-title":"CBR1 rs9024 genotype status impacts the bioactivation of loxoprofen in human liver","volume":"39","author":"Qui\u00f1ones-Lombra\u00f1a","year":"2018","journal-title":"Biopharm Drug Dispos."},{"key":"10.1016\/j.cbi.2026.112315_bib190","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-03208-9","article-title":"Pharmacogenetics of induction therapy-related toxicities in childhood acute lymphoblastic leukemia patients treated with UKALL 2003 protocol","volume":"11","author":"Aslam","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cbi.2026.112315_bib181","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1124\/dmd.107.014779","article-title":"A functional genetic polymorphism on human carbonyl reductase 1 (CBR1 V88I) impacts on catalytic activity and NADPH binding affinity","volume":"35","author":"Gonzalez-Covarrubias","year":"2007","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.cbi.2026.112315_bib182","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1007\/s11095-008-9592-5","article-title":"Inhibition of polymorphic human carbonyl reductase 1 (CBR1) by the cardioprotectant flavonoid 7-monohydroxyethyl rutoside (monoHER)","volume":"25","author":"Gonzalez-Covarrubias","year":"2008","journal-title":"Pharm. Res."},{"key":"10.1016\/j.cbi.2026.112315_bib193","doi-asserted-by":"crossref","first-page":"E94","DOI":"10.1002\/mc.22187","article-title":"NNK reduction pathway gene polymorphisms and risk of lung cancer","volume":"54","author":"Modesto","year":"2015","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.cbi.2026.112315_bib194","first-page":"6291","article-title":"Association between CBR1 polymorphisms and NSCLC in the Chinese population","volume":"14","author":"Guo","year":"2017","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.cbi.2026.112315_bib195","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.70114","article-title":"The Influence of CYP2B6, GSTP1, and SLCO1B1 star allele-predicted phenotypes and CBR1 genetic variants on effectiveness outcomes in patients with hepatocellular carcinoma receiving doxorubicin via transarterial chemoembolization","volume":"13","author":"Shilbayeh","year":"2025","journal-title":"Pharmacol. Res. Perspect."},{"key":"10.1016\/j.cbi.2026.112315_bib191","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1080\/00498254.2024.2330493","article-title":"Effects of pharmacogenetics on pharmacokinetics and toxicity of doxorubicin in Egyptian breast cancer patients","volume":"54","author":"Ebaid","year":"2024","journal-title":"Xenobiotica"},{"key":"10.1016\/j.cbi.2026.112315_bib192","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119392","article-title":"Association between the genetic polymorphisms of the pharmacokinetics of anthracycline drug and myelosuppression in a patient with breast cancer with anthracycline-based chemotherapy","volume":"276","author":"Cui","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.cbi.2026.112315_bib186","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1007\/s00280-016-3166-8","article-title":"Population pharmacokinetics of daunorubicin in adult patients with acute myeloid leukemia","volume":"78","author":"Varatharajan","year":"2016","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.cbi.2026.112315_bib184","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.3390\/medicina60091540","article-title":"Sanger sequencing reveals novel variants in GLO-1, ACE, and CBR1 genes in patients of early and severe diabetic nephropathy","volume":"60","author":"Shah","year":"2024","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.cbi.2026.112315_bib183","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1124\/dmd.108.024711","article-title":"Two nonsynonymous single nucleotide polymorphisms of human carbonyl reductase 1 demonstrate reduced in vitro metabolism of daunorubicin and doxorubicin","volume":"37","author":"Bains","year":"2009","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.cbi.2026.112315_bib185","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1111\/j.1349-7006.2008.00903.x","article-title":"CBR1 and CBR3 pharmacogenetics and their influence on doxorubicin disposition in Asian breast cancer patients","volume":"99","author":"Lal","year":"2008","journal-title":"Cancer Sci."},{"key":"10.1016\/j.cbi.2026.112315_bib187","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1200\/JCO.2011.34.8987","article-title":"Anthracycline-related cardiomyopathy after childhood cancer: role of polymorphisms in carbonyl reductase genes--a report from the Children's Oncology Group","volume":"30","author":"Blanco","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.cbi.2026.112315_bib188","doi-asserted-by":"crossref","first-page":"4051","DOI":"10.3390\/ijms26094051","article-title":"Drugs metabolism-related genes variants impact on anthracycline-based chemotherapy induced subclinical cardiotoxicity in breast cancer patients","volume":"26","author":"Vaitiekus","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cbi.2026.112315_bib189","first-page":"2173","article-title":"Risk factors for anthracycline-associated cardiotoxicity","volume":"24","author":"Reinbolt","year":"2016","journal-title":"Support. Care Cancer"},{"key":"10.1016\/j.cbi.2026.112315_bib196","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1186\/s12967-017-1339-9","article-title":"Polymorphisms at microRNA binding sites of Ara-C and anthracyclines-metabolic pathway genes are associated with outcome of acute myeloid leukemia patients","volume":"15","author":"Cao","year":"2017","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.cbi.2026.112315_bib197","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/ejh.12243","article-title":"Host genome variations and risk of infections during induction treatment for childhood acute lymphoblastic leukemia","volume":"92","author":"Lund","year":"2014","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.cbi.2026.112315_bib198","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1017\/S0033291719000618","article-title":"Pathway-based polygene risk for severe depression implicates drug metabolism in CONVERGE","volume":"50","author":"Docherty","year":"2020","journal-title":"Psychol. Med."},{"key":"10.1016\/j.cbi.2026.112315_bib199","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1007\/s11095-013-1267-1","article-title":"Interindividual variability in the cardiac expression of anthracycline reductases in donors with and without Down syndrome","volume":"31","author":"Qui\u00f1ones-Lombra\u00f1a","year":"2014","journal-title":"Pharm. Res."}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279726004230?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279726004230?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:24:39Z","timestamp":1791231879000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279726004230"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":202,"alternative-id":["S0009279726004230"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2026.112315","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Carbonyl reductase 1: A redox-regulating carbonyl detoxification enzyme in health and disease","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2026.112315","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"112315"}}